Cardiovascular Disease Risk amongst African Black Patients with Rheumatoid Arthritis: The Need for Population Specific Stratification

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Solomon, Ahmed ^a   Tsang, Linda ^b   Woodiwiss, Angela J ^b   Millen, Aletta M E ^b   Norton, Gavin R ^b   Dessein, Patrick H ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; INTERLEUKIN 5; INTERLEUKIN 6;

AFRICAN; ATHEROSCLEROSIS; BLACK PERSON; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ETHNIC DIFFERENCE; HUMAN; METABOLIC SYNDROME X; OBESITY; PREVALENCE; REVIEW; RHEUMATOID ARTHRITIS; ARTHRITIS, RHEUMATOID; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; PATHOLOGY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VASCULAR ENDOTHELIUM;

ADIPOKINES; AFRICAN CONTINENTAL ANCESTRY GROUP; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; RISK FACTORS;

EID: 84935838948     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/826095     Document Type: Review

References (80)

1. S. E. Gabriel, "Why do people with rheumatoid arthritis still die prematurely?" Annals of the Rheumatic Diseases, vol. 67, supplement 3, pp. iii30-iii34, 2008.
2. P.H.Dessein and B. I. Joffe, "When is a patient with rheumatoid arthritis at risk for cardiovascular disease?" Journal of Rheumatology, vol. 33, no. 2, pp. 201-203, 2006.
3. A. Gonzalez, H. M. Kremers, C. S. Crowson et al., "The widening mortality gap between rheumatoid arthritis patients and the general population," Arthritis and Rheumatism, vol. 56, no. 11, pp. 3583-3587, 2007.
4. M. Holmqvist, E. Gransmark, A. Mantel et al., "Occurrence and relative risk of stroke in incident and prevalent contemporary rheumatoid arthritis," Annals of the Rheumatic Diseases, vol. 72, pp. 541-546, 2013.
5. J. A. Aviña-Zubieta, H. K. Choi, M. Sadatsafavi, M. Etminan, J. M. Esdaile, and D. Lacaille, "Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies," Arthritis Care & Research, vol. 59, no. 12, pp. 1690-1697, 2008.
6. C. Meune, E. Touzé, L. Trinquart, and Y. Allanore, "High risk of clinical cardiovascular events in rheumatoid arthritis: Levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis," Archives of Cardiovascular Diseases, vol. 103, no. 4, pp. 253-261, 2010.
7. K. M. J. Douglas, A. V. Pace, G. J. Treharne et al., "Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome," Annals of the Rheumatic Diseases, vol. 65, no. 3, pp. 348-353, 2006.
8. P. H. Dessein, B. I. Joffe, M. G. Veller et al., "Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis," Journal of Rheumatology, vol. 32, no. 3, pp. 435-442, 2005.
9. I. Del Rincón, G. L. Freeman, R. W. Haas, D. H. OLeary, and A. Escalante, "Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis," Arthritis and Rheumatism, vol. 52, no. 11, pp. 3413-3423, 2005.
10. P. H. Dessein, G. R. Norton, A. J. Woodiwiss, B. I. Joffe, and F. Wolfe, "Influence of nonclassical cardiovascular-risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis," Journal of Rheumatology, vol. 34, no. 5, pp. 943-951, 2007.
11. D. H. Solomon, J. Kremer, J. R. Curtis et al., "Explaining the cardiovascular risk associated with rheumatoid arthritis: Traditional risk factors versus markers of rheumatoid arthritis severity," Annals of the Rheumatic Diseases, vol. 69, no. 11, pp. 1920-1925, 2012.
12. M. A. Gonzalez-Gay, C. Gonzalez-Juanatey, M. J. Lopez-Diaz et al., "HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascularmortality in patients with rheumatoid arthritis," Arthritis Care and Research, vol. 57, no. 1, pp. 125-132, 2007.
13. T. E. Toms,V. F. Panoulas, J. P. Smith et al., "Rheumatoid arthritis susceptibility genes associate with lipid levels in patientswith rheumatoid arthritis," Annals of the Rheumatic Diseases, vol. 70, no. 6, pp. 1025-1032, 2011.
14. N. Sattar, D. W. McCarey, H. Capell, and I. B. McInnes, "Explaining how high-grade systemic inflammation accelerates vascular risk in rheumatoid arthritis," Circulation, vol. 108, no. 24, pp. 2957-2963, 2003.
15. G. D. Kitas and S. E. Gabrie, "Cardiovascular disease in rheumatoid arthritis: State of the art and future perspectives," Annals of the Rheumatic Diseases, vol. 70, no. 1, pp. 8-14, 2011.
16. P. H. Dessein, A. E. Stanwix, and B. I. Joffe, "Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: Acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis," Arthritis Research, vol. 4, no. 5, article R5, 2002.
17. P. H. Dessein, B. I. Joffe, and A. E. Stanwix, "Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: A pilot study," Arthritis Research & Therapy, vol. 4, article R12, 2002.
18. P. H. Dessein and B. I. Joffe, "Insulin resistance and impaired beta cell function in rheumatoid arthritis," Arthritis and Rheumatism, vol. 54, no. 9, pp. 2765-2775, 2006.
19. J. F. Boyer, P. A. Gourraud, A. Cantagrel, J. L. Davignon, and A. Constantin, "Traditional cardiovascular risk factors in rheumatoid arthritis: A meta-analysis," Joint Bone Spine, vol. 78, no. 2, pp. 179-183, 2011.
20. P. H. Dessein, B. I. Joffe, and S. Singh, "Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis.," Arthritis Research & Therapy, vol. 7, no. 3, pp. R634-R643, 2005.
21. P. H. Dessein and B. I. Joffe, "Suppression of circulating interleukin-6 concentrations is associated with decreased endothelial activation in rheumatoid arthritis," Clinical and Experimental Rheumatology, vol. 24, no. 2, pp. 161-167, 2006.
22. P. H. Dessein and A. G. Semb, "Could cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced?" Annals of the Rheumatic Diseases, vol. 72, no. 11, pp. 1743-1746, 2013.
23. C. S.Crowson, E. L.Matteson, V. L. Roger, T. M.Therneau, and S. E. Gabriel, "Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis," The American Journal of Cardiology, vol. 110, no. 3, pp. 420-424, 2012.
24. E.Arts, "Atransatlantic risk calculator for rheumatoid arthritis," Annals of the RheumaticDiseases, vol. 73, supplement 2,pp. 123-124, 2014.
25. K. Steyn, K. Sliwa, S. Hawken et al., "Risk factors associated withmyocardial infarction in Africa:The INTERHEART Africa Study," Circulation, vol. 112, no. 23, pp. 3554-3561, 2005.
26. S. Yusuf, S. Reddy, S. Ôunpuu, and S. Anand, "Global burden of cardiovascular diseases. Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization," Circulation, vol. 104, no. 22, pp. 2746-2753, 2001.
27. M. D. Connor, "Carotid artery disease in sub-Saharan Africa: A marker of epidemiological and stroke transition," Neuroepidemiology, vol. 38, no. 2, pp. 120-121, 2012.
28. D. Bradshaw, V. Pillay-van Wyk, and R. Laubscher, "Cause of death statistics for South Africa: Challenge and possibilities for improvement," South African Medical Research Council Report, 2010.
29. A. K. Paul, B. Mash, and G. Rupesinghe, "Peripheral arterial disease-High prevalence in rural black South Africans," South African Medical Journal, vol. 97, no. 4, pp. 285-288, 2007.
30. K. Sliwa, D. Wilkinson, C. Hansen et al., "Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): A cohort study," The Lancet, vol. 371, no. 9616, pp. 915-922, 2008.
31. M. D. Connor, G. Modi, and C. P. Warlow, "Differences in the nature of stroke in amultiethnic urban south african population the Johannesburg Hospital stroke register," Stroke, vol. 40, no. 2, pp. 355-362, 2009.
32. The SASPI Project Team, "Prevalence of stroke survivors in rural South Africa: Results from the Southern African Stroke Prevention Initiative (SASPI) Agincourt Field Site," Stroke, vol. 35, no. 3, pp. 627-632, 2004.
33. M. D. Connor, R. Walker, G. Modi, and C. P. Warlow, "Burden of stroke in black populations in sub-Saharan Africa," Lancet Neurology, vol. 6, no. 3, pp. 269-278, 2007.
34. M. O. Owolabi and A. M. Agunloye, "Which risk factors are more associated with ischemic rather than hemorrhagic stroke in black Africans?" Clinical Neurology and Neurosurgery, vol. 115, no. 10, pp. 2069-2074, 2013.
35. H. H. Vorster, "The emergence of cardiovascular disease during urbanisation of Africans," Public Health Nutrition, vol. 5, no. 1A, pp. 239-243, 2002.
36. A. E. Sumner, J. Zhou, A. Doumatey et al., "Low HDLcholesterol with normal triglyceride levels is the most common lipid pattern in West Africans and African Americans with Metabolic Syndrome: Implications for cardiovascular disease prevention," CVD Prevention and Control, vol. 5, no. 3, pp. 75-80, 2010.
37. M. Ntsekhe and A. Damasceno, "Recent advances in the epidemiology, outcome, and prevention of myocardial infarction and stroke in sub-Saharan Africa," Heart, vol. 99, no. 17, pp. 1230-1235, 2013.
38. M. Thorogood, M. Connor, S. Tollman, G. Lewando Hundt, G. Fowkes, and J. Marsh, "A cross-sectional study of vascular risk factors in a rural South African population: Data from the Southern African Stroke Prevention Initiative (SASPI)," BMC Public Health, vol. 7, article 326, 2007.
39. N. Peer, K. Steyn, C. Lombard, N. Gwebushe, and N. Levitt, "A high burden of hypertension in the urban black population of Cape Town: The Cardiovascular risk in Black South Africans (CRIBSA) Study," PLoS ONE, vol. 8, no. 11, Article ID e78567, 2013.
40. N. Peer, K. Steyn, C. Lombard, E. V. Lambert, B. Vythilingum, and N. S. Levitt, "Rising diabetes prevalence among urbandwelling black South Africans," PLoS ONE, vol. 7, no. 9, Article ID e43336, 2012.
41. T. Puoane, K. Steyn, D. Bradshaw et al., "Obesity in South Africa: The South African demographic and health survey," Obesity Research, vol. 10, no. 10, pp. 1038-1048, 2002.
42. A.A.Herman, D. J. Stein, S. Seedat, S. G. Heeringa,H.Moomal, and D. R. Williams, "The South African Stress and Health (SASH) study: 12-month and lifetime prevalence of common mental disorders," South African Medical Journal, vol. 99, no. 5, pp. 339-344, 2009.
43. C. D. Libhaber, A. J. Woodiwiss, H. L. Booysen et al., "Differential relationships of systolic and diastolic blood pressure with components of left ventricular diastolic dysfunction," Journal of Hypertension, vol. 32, no. 4, pp. 912-920, 2014.
44. B. Adeboye, G. Bermano, and C. Rolland, "Obesity and its health impact in Africa: A systematic review," Cardiovascular Journal of Africa, vol. 23, no. 9, pp. 512-521, 2012.
45. C. D. Libhaber, G. R. Norton, O. H. I. Majane et al., "Contribution of central and general adiposity to abnormal left ventricular diastolic function in a community sample with a high prevalence of obesity," The American Journal of Cardiology, vol. 104, no. 11, pp. 1527-1533, 2009.
46. L. Stein, M. I. Urban, M. Weber et al., "Effects of tobacco smoking on cancer and cardiovascular disease in urban black South Africans," The British Journal of Cancer, vol. 98, no. 9, pp. 1586-1592, 2008.
47. A. J. Woodiwiss, L. Scott, M. J. Maseko et al., "Relationship of predominantly mild current smoking to out-of-office blood pressure in a community sample in Africa," Journal of Hypertension, vol. 29, no. 5, pp. 854-862, 2011.
48. P. C. Venter, L. Malan, and A. E. Schutte, "Psychosocial stress but not hypertensive status associated with angiogenesis in Africans," Blood Pressure, 2014.
49. P. H. Dessein, A. J. Woodiwiss, G. R. Norton, and A. Solomon, "Rheumatoid arthritis is associated with reduced adiposity but not with unfavorable major cardiovascular risk factor profiles and enhanced carotid atherosclerosis in black Africans from a developing population: A cross-sectional study," Arthritis Research & Therapy, vol. 15, p. R96, 2013.
50. I. C. Chikanza, M. Stein, S. Lutalo, and T. Gibson, "The clinical, serologic and radiologic features of rheumatoid arthritis in ethnic black Zimbabwean and British Caucasian patients," Journal of Rheumatology, vol. 21, no. 11, pp. 2011-2015, 1994.
51. A. Solomon, B. F. Christian, G. R. Norton, A. J.Woodiwiss, and P. H. Dessein, "Risk factor profiles for atherosclerotic cardiovascular disease in black and other Africans with established rheumatoid arthritis," Journal of Rheumatology, vol. 37, no. 5, pp. 953-960, 2010.
52. A. Solomon, A. J. Woodiwiss, A. T. Abdool-Carrim, B. A. Stevens, G. R. Norton, and P. H. Dessein, "The carotid artery atherosclerosis burden and its relation to cardiovascular risk factors in black and white Africans with established rheumatoid arthritis: A cross-sectional study," Journal of Rheumatology, vol. 39, no. 9, pp. 1798-1806, 2012.
53. A. Solomon, G. R. Norton, A. J. Woodiwiss, and P. H. Dessein, "Obesity and carotid atherosclerosis in African black and Caucasian women with established rheumatoid arthritis: A crosssectional study," Arthritis Research & Therapy, vol. 14, no. 2, article R67, 2012.
54. P. H. Dessein, G. R. Norton, B. I. Joffe, A. T. Abdool-Carrim, A. J. Woodiwiss, and A. Solomon, "Metabolic cardiovascular risk burden and atherosclerosis in African black and Caucasian women with rheumatoid arthritis: A cross-sectional study," Clinical and Experimental Rheumatology, vol. 31, no. 1, pp. 53-61, 2013.
55. P. H. Dessein, A. Solomon, A. J. Woodiwiss, G. R. Norton, L. Tsang, and M. A. Gonzalez-Gay, "Marked independent relationship between circulating interleukin-6 concentrations and endothelial activation in rheumatoid arthritis," Mediators of Inflammation, vol. 2013,Article ID 510243, 10 pages, 2013.
56. A. Södergren, K. Karp, K. Boman et al., "Atherosclerosis in early rheumatoid arthritis:Very early endothelial activation and rapid progression of intima media thickness," Arthritis Research and Therapy, vol. 12, no. 4, article R158, 2010.
57. H. R. Young, C. P. Chung, A. Oeser et al., "Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis," Arthritis Care and Research, vol. 61, no. 11, pp. 1580-1585, 2009.
58. H. Yamawaki, "Vascular effects of novel adipocytokines: Focus on vascular contractility and inflammatory responses," Biological and Pharmaceutical Bulletin, vol. 34, no. 3, pp. 307-310, 2011.
59. J.L.Rourke,H. J.Dranse, and C. J. Sinal, "Towards an integrative approach to understanding the role of chemerin in human health and disease," Obesity Reviews, vol. 14, no. 3, pp. 245-262, 2013.
60. R. Gómez, J. Conde, M. Scotece, J. J. Gómez-Reino, F. Lago, and O. Gualillo, "Whats new in our understanding of the role of adipokines in rheumatic diseases?" Nature Reviews Rheumatology, vol. 7, no. 9, pp. 528-536, 2011.
61. K. Kaneko, Y. Miyabe, A. Takayasu et al., "Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis," Arthritis Research&Therapy, vol. 13,no. 5, articleR158, 2011.
62. K. Eisinger, S. Bauer, A. Schäffler et al., "Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patientswith rheumatoid arthritis and osteoarthritis," Experimental and Molecular Pathology, vol. 92, no. 1, pp. 90-96, 2012.
63. M. M. J. Herenius, A. S. F. Oliveira, C. A. Wijbrandts, D. M. Gerlag, P. P. Tak, and M. C. Lebre, "Anti-TNF therapy reduces serumlevels of chemerin in rheumatoid arthritis: A new mechanism by which anti-TNF might reduce inflammation," PLoS ONE, vol. 8, no. 2, Article ID e57802, 2013.
64. P. H. Dessein and A. Solomon, "Towards the elucidation of the true impact of adipocytokines on cardiovascular risk in rheumatoid arthritis," Arthritis Research & Therapy, vol. 15, no. 6, p. 127, 2013.
65. M. A. Gonzalez-Gay, M. T. Garcia-Unzueta, A. Berja et al., "Anti-TNF-α therapy does not modulate leptin in patients with severe rheumatoid arthritis," Clinical and Experimental Rheumatology, vol. 27, no. 2, pp. 222-228, 2009.
66. M. A. Gonzalez-Gay, J. Llorca, M. T. Garcia-Unzueta et al., "High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis," Clinical and Experimental Rheumatology, vol. 26, no. 4, pp. 596-603, 2008.
67. M. A. Gonzalez-Gay, M. T. Garcia-Unzueta, C. Gonzalez-Juanatey et al., "Anti-TNF-α therapy modulates resistin in patients with rheumatoid arthritis," Clinical and Experimental Rheumatology, vol. 26, no. 2, pp. 311-316, 2008.
68. M. A. Gonzalez-Gay, T. R. Vazquez-Rodriguez, M. T. Garcia-Unzueta et al., "Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-α therapy," Clinical and Experimental Rheumatology, vol. 28, no. 1, pp. 56-62, 2010.
69. P. H. Dessein, G. R. Norton, M. Badenhorst, A. J. Woodiwiss, and A. Solomon, "Rheumatoid arthritis impacts on the independent relationships between circulating adiponectin concentrations and cardiovascularmetabolic risk," Mediators of Inflammation, vol. 2013,Article ID 461849, 9 pages, 2013.
70. P. H. Dessein, A. J. Woodiwiss, G. R. Norton, L. Tsang, and A. Solomon, "Independent associations of total and high molecular weight adiponectin with cardiometabolic risk and surrogate markers of enhanced early atherogenesis in black and white patients with rheumatoid arthritis: A cross-sectional study," Arthritis Research & Therapy, vol. 15, no. 5, article R128, 2013.
71. P. H. Dessein, G. R. Norton, A. J. Woodiwiss, L. Tsang, and A. Solomon, "Age impacts on the independent relationships of leptin with cardiometabolic risk and surrogate markers of enhanced early atherogenesis in black and white patients with rheumatoid arthritis: A cross-sectional study," Rheumatology International, vol. 34, no. 3, pp. 329-339, 2014.
72. P. H. Dessein, L. Tsang, A. J. Woodiwiss, G. R. Norton, and A. Solomon, "The novel adipokine chemerin is a biomarker of cardiovascular disease risk in patients with rheumatoid arthritis," Journal of Rheumatology, 2014.
73. P. H. Dessein, L. Tsang, G. R. Norton, A. J. Woodiwiss, and A. Solomon, "Retinol binding protein 4 concentrations relate to enhanced atherosclerosis in obese patients with rheumatoid arthritis," PLoS ONE, vol. 9, no. 3,Article ID e92739, 2014.
74. P. H. Dessein, L. Tsang, A. Solomon, A. J. Woodiwiss, A. M. E. Millen, and G. R. Norton, "Adiponectin and atherosclerosis in rheumatoid arthritis," Mediators of Inflammation, vol. 2014, Article ID 525891, 10 pages, 2014.
75. P. H. Dessein, L. Tsang, A. J. Woodiwiss, and A. Solomon, "Traditional cardiovascular risk factors impact on the independent relationship of leptin with atherosclerosis in rheumatoid arthritis," The Journal of Rheumatology. In press.
76. P.H. Dessein, G. R.Norton, A. J. Woodiwiss, and A. Solomon, "Independent relationship between circulating resistin concentrations and endothelial activation in rheumatoid arthritis," Annals of the Rheumatic Diseases, vol. 72, no. 9, pp. 1586-1588, 2013.
77. P. H. Dessein, L. Tsang, A. J. Woodiwiss, H. C. Hsu, G. R. Norton, and A. Solomon, "The leukocyte count influences the relationship of circulating resistin concentrations with advanced atherosclerosis in rheumatoid arthritis , Clin Exp Rheumatol," in press, 2014.
78. D. H. Solomon, J. Z. Ayanian, E. Yelin, T. Shaykevich, M. A. Brookhart, and J. N. Katz, "Use of disease-modifying medications for rheumatoid arthritis by race and ethnicity in the national ambulatory medical care survey," Arthritis Care and Research, vol. 64, no. 2, pp. 184-189, 2012.
79. L. Chu, C. Portugal, A. A. Kawatkar, W. Stohl, and M. B. Nichol, "Racial/ethnic differences in the use of biologic diseasemodifying antirheumatic drugs among California Medicaid rheumatoid arthritis patients," Arthritis Care and Research, vol. 65, no. 2, pp. 299-303, 2013.
80. M. E. Suarez-Almazor, J. P. Berrios-Rivera, V. Cox, N. M. Janssen, D. M. Marcus, and S. Sessoms, "Initiation of diseasemodifying antirheumatic drug therapy in minority and disadvantaged patients with rheumatoid arthritis," Journal of Rheumatology, vol. 34, no. 12, pp. 2400-2407, 2007.